Entera Bio (ENTX) Depreciation and Depletion (2021 - 2026)
Entera Bio (ENTX) recorded quarterly Depreciation and Depletion of $7000.0 in Q1 2026, little changed on a QoQ basis from $7000.0 in Q4 2025, and down 12.5% year-over-year from $8000.0 in Q1 2025.
Entera Bio (ENTX) Depreciation and Depletion (2021 - 2026) Analysis & Trends
Entera Bio has disclosed Depreciation and Depletion across 6 years of filings, most recently posting $7000.0 for Q1 2026.
- Quarterly Depreciation and Depletion fell 12.5% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29000.0 (down 29.27% YoY) and the FY2025 annual result came in at $30000.0, down 34.78% from the prior year.
- Depreciation and Depletion steadied at $7000.0 in Q1 2026, from $7000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $16000.0 in Q1 2022 and troughed at $7000.0 in Q2 2025.
- A 5-year average of $11941.2 and a median of $13000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion surged 77.78% — and 2025, when it slumped 38.46%.
- Tracing ENTX's Depreciation and Depletion over 5 years: stood at $16000.0 in 2022, then decreased by 18.75% to $13000.0 in 2023, then dropped by 15.38% to $11000.0 in 2024, then tumbled by 36.36% to $7000.0 in 2025, then changed by 0.0% to $7000.0 in 2026.
- Business Quant data shows ENTX's Depreciation and Depletion at $7000.0 in Q1 2026, $7000.0 in Q4 2025, and $8000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Entera Bio | 57.79 Mn | 53.65 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Dec 31, 2023 | 13,000.00 |